NEW YORK (GenomeWeb News) – The National Cancer Institute plans to fund small businesses undertaking projects to develop new molecular or cellular analysis tools for use in cancer research and clinical care, according to a new funding announcement.

These Small Business Innovation Research grants will fund R&D projects under NCI's Innovative Molecular Analysis Technology (IMAT) program, which supports early-stage development and validation of high-risk, high-payoff tools that improve the molecular or cellular analysis of cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.